Skip to main content

Table 3 Antianxiety activity of synthesized compounds

From: Synthesis and evaluation of substituted diphenyl-1,3,4-oxadiazole derivatives for central nervous system depressant activity

Number

Compound

Dose (mg kg-1)

Number of entries in open arms (Mean ± S.E.M)

Average time spent in open arms (Mean ± S.E.M)

1.

Control

10

2.10 ± 0.23

9.77 ± 0.27

2.

Standard

10

12.66 ± 0.33

32.66 ± 0.33

3.

XIII

10

13.33 ± 0.21***

68.00 ± 0.36***

4.

XIV

10

17.00 ± 0.36***

62.33 ± 0.21**

5.

XV

10

21.50 ± 0.42***

76.83 ± 0.30***

6.

XVI

10

8.83 ± 0.30***

45.83 ± 0.30**

7.

XVII

10

13.66 ± 0.42

52.66 ± 0.33*

  1. Values are mean ± SEM of six animals in each group. Statistical significance versus standard (***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05)